The total number of records retrieved from this search are 22. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_1842	Herpes simplex virus	NV1023	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	0.01 MOI	100% cell survival after day 1	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1843	Herpes simplex virus	NV1024	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	0.01 MOI	100% cell survival after day 3	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1844	Herpes simplex virus	NV1025	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	0.01 MOI	80% cell survival after day 5	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1845	Herpes simplex virus	NV1026	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	0.01 MOI	70% cell survival after day 7	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1846	Herpes simplex virus	NV1027	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	0.1 MOI	90% cell survival after day 1	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1847	Herpes simplex virus	NV1028	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	0.1 MOI	90% cell survival after day 3	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1848	Herpes simplex virus	NV1029	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	0.1 MOI	80% cell survival after day 5	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1849	Herpes simplex virus	NV1030	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	0.1 MOI	60% cell survival after day 7	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1850	Herpes simplex virus	NV1031	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	1 MOI	70% cell survival after day 1	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1851	Herpes simplex virus	NV1032	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	1 MOI	65% cell survival after day 3	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1852	Herpes simplex virus	NV1033	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	1 MOI	50% cell survival after day 5	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1853	Herpes simplex virus	NV1034	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	1 MOI	20% cell survival after day 7	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_2280	Vesicular stomatitis virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Pancreatic ductal adeonocarcinoma cell line	Hs766T	80% confluent monolayer	NA	MTT assay	1 MOI	5% cell survival after 5 days	No	No	NA	No response	NA	NA	Downregulation of IFN-Gamma	NA	22238308
OV_2294	Vesicular stomatitis virus	VSV-Delta-M51-GFP	RNA	Rhabdoviridae	Deletion of M51 gene and insertion of GFP gene	Yes	No	No	ATCC	Pancreatic ductal adeonocarcinoma cell line	Hs766T	80% confluent monolayer	NA	MTT assay	1 MOI	50% cell survival after 5 days	No	No	NA	No response	NA	NA	Downregulation of IFN-Gamma	NA	22238308
OV_2308	Vesicular stomatitis virus	VSV-p1-GFP	RNA	Rhabdoviridae	Insertion of P gene	Yes	No	No	ATCC	Pancreatic ductal adeonocarcinoma cell line	Hs766T	80% confluent monolayer	NA	MTT assay	1 MOI	20% cell survival after 5 days	No	No	NA	No response	NA	NA	Downregulation of IFN-Gamma	NA	22238308
OV_2322	Vesicular stomatitis virus	Sev-GFP	RNA	Rhabdoviridae	Insertion of GFP gene	Yes	No	No	ATCC	Pancreatic ductal adeonocarcinoma cell line	Hs766T	80% confluent monolayer	NA	MTT assay	1 MOI	100% cell survival after 5 days	No	No	NA	No response	NA	NA	Downregulation of IFN-Gamma	NA	22238308
OV_2336	Vesicular stomatitis virus	RSV-GFP	RNA	Rhabdoviridae	Insertion of GFP gene	Yes	No	No	ATCC	Pancreatic ductal adeonocarcinoma cell line	Hs766T	80% confluent monolayer	NA	MTT assay	1 MOI	60% cell survival after 5 days	No	No	NA	No response	NA	NA	Downregulation of IFN-Gamma	NA	22238308
OV_2350	Vesicular stomatitis virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Pancreatic ductal adeonocarcinoma cell line	Hs766T	80% confluent monolayer	NA	MTT assay	0.01 MOI	20% cell survival after 5 days	No	No	NA	No response	NA	NA	Downregulation of IFN-Gamma	NA	22238308
OV_2364	Vesicular stomatitis virus	VSV-Delta-M51-GFP	RNA	Rhabdoviridae	Deletion of M51 gene and insertion of GFP gene	Yes	No	No	ATCC	Pancreatic ductal adeonocarcinoma cell line	Hs766T	80% confluent monolayer	NA	MTT assay	0.01 MOI	90% cell survival after 5 days	No	No	NA	No response	NA	NA	Downregulation of IFN-Gamma	NA	22238308
OV_2378	Vesicular stomatitis virus	VSV-p1-GFP	RNA	Rhabdoviridae	Insertion of P gene	Yes	No	No	ATCC	Pancreatic ductal adeonocarcinoma cell line	Hs766T	80% confluent monolayer	NA	MTT assay	0.01 MOI	30% cell survival after 5 days	No	No	NA	No response	NA	NA	Downregulation of IFN-Gamma	NA	22238308
OV_2392	Vesicular stomatitis virus	Sev-GFP	RNA	Rhabdoviridae	Virus expressing GFP gene	Yes	No	No	ATCC	Pancreatic ductal adeonocarcinoma cell line	Hs766T	80% confluent monolayer	NA	MTT assay	0.01 MOI	100% cell survival after 5 days	No	No	NA	No response	NA	NA	Downregulation of IFN-Gamma	NA	22238308
OV_2406	Vesicular stomatitis virus	RSV-GFP	RNA	Rhabdoviridae	Virus expressing GFP gene	Yes	No	No	ATCC	Pancreatic ductal adeonocarcinoma cell line	Hs766T	80% confluent monolayer	NA	MTT assay	0.01 MOI	100% cell survival after 5 days	No	No	NA	No response	NA	NA	Downregulation of IFN-Gamma	NA	22238308